NWU22-12-01
OPEN TO ACCRUAL
PH2 Placebo-Controlled Trial of Urolithin a in Prostate Cancer Undergoing Radical Prostatectomy
S2312
OPEN TO ACCRUAL
Phase III Study of Cabazitaxel w/ or w/o Carboplatin in MCRPC Patients
UW22067
OPEN TO ACCRUAL
PET/CT Characterization of Treatment Resistance of AR-targeted therapies in mCRPC
UW24008
OPEN TO ACCRUAL
Ph 1b, HC-7366 in Combo w/ Belzutifan (WELIREG TM) or Cabozantinib with Inoperable or Metastatic RCC
UW24109
OPEN TO ACCRUAL
Ph1: Safety+Tolerability of Novel ACK1 Inhibitor (R)-9bMS in Patients with Prostate Cancer (PHAROS)
UW24138
OPEN TO ACCRUAL
P3: Xaluritamig vs Cabazitaxel or 2nd Androgen Receptor-Directed Therapy w/progressive mCRPC
UW25078
OPEN TO ACCRUAL
A Phase 2 Study to Evaluate the Effects of ASP5541 in Participants with Prostate Cancer